CrowdfundedWealth

Monroe Capital Income Plus NAV $9.70: Tender Proration, Payout

ResearchBy JorgeUpdated November 7, 202629 min read7 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Vehicle file: Monroe Capital Income Plus Corp — assets, distributions, repurchases and every filing, as filed with the SEC.Open the file →

Updated October 21, 2026 — NAV $9.70 and an $8.1 million October closing. The Form 8-K of October 20, 2026 (accession 0001742313-26-000062) sets NAV per share at $9.70 on September 30, down from $9.75 on August 31, reports 839,725 shares sold on October 1 at $9.70 for $8,145,328 (less than the $9,404,050 of September 1, so the October closing is now the smallest in the filings we read) and declares another $0.068 distribution, payable on or about October 28. We checked EDGAR on October 21 and no Schedule TO for a fourth-quarter tender offer had been filed since the August one; one was filed on October 28 (see the next paragraph). The September 30 balance sheet came with the 10-Q of November 6, 2026; see the November 7 note below.

Updated October 30, 2026 — the twentieth tender offer is open. On October 28, 2026 MCIP filed a Schedule TO-I (accession 0001104659-26-119625) offering to buy up to 13,493,156 shares, about 5.0% of the 269,863,125 shares outstanding at September 30, 2026. The offer expires at 11:59 p.m. Eastern on November 30, 2026. The price is the NAV per share at the last private-offering closing before expiry, a closing the Offer to Purchase expects on or about November 2, 2026; the latest closing it quotes, October 1, was at $9.70, which makes the maximum cost about $130.9 million. Shares bought on or after October 28, 2025 are locked up and cannot be tendered.

Updated November 7, 2026 — the September 30 10-Q is out: NAV $9.70, debt down, non-accruals down. MCIP's Form 10-Q filed November 6, 2026 (accession 0001742313-26-000066) reports net assets of $2,616,998,000 and 269,863,125 shares at September 30, so NAV per share is $9.70 (it was $9.87 at December 31, 2025). Debt principal fell to $3,106.5 million from $3,454.0 million at June 30 (1.19 times net assets, our arithmetic; asset coverage 184%, up from 178%) after the fund invested $183.0 million and received $614.7 million of sales and principal repayments in the quarter. Borrowers on non-accrual fell to 17 with a fair value of $48.8 million (0.9% of investments at fair value; 19 and $71.4 million at June 30). Net investment income was $59.3 million in the quarter against $56.4 million of distributions declared (105.2%, our arithmetic) and $190.3 million against $180.1 million for the nine months (105.6%). Repurchases were $135.5 million in the quarter (the August offer) and $424.6 million in the nine months. Subsequent events: $16.5 million of shares sold after quarter-end (October 1 and November 2), a $0.068 distribution paid October 28, and the twentieth tender offer, open until November 30, 2026, at the NAV on October 31, 2026. The debt, net assets, asset coverage, non-accrual and distribution figures below now run to September 30 where the tables say so.

Quick answer

Monroe Capital Income Plus Corporation (MCIP, CIK 1742313), a private non-traded BDC with $2,616,998,000 of net assets at September 30, 2026, bought every share tendered in its first 17 quarterly offers, then prorated twice in a row. Per its Schedule TO-I/A of September 4, 2026, 17,848,959 shares were tendered in the offer that expired August 31, 2026 and it accepted 13,872,183 (77.7%) at $9.77, a total of $135,531,230. In May, 25,287,143 were tendered and it accepted 14,229,101 (56.3%). Its Form 8-K of October 20, 2026 set NAV at $9.70 per share on September 30 (it was $9.75 on August 31 and $10.39 at September 30, 2024), declared a $0.068 distribution and reported $8.1 million of new shares sold on October 1, the smallest monthly closing in the filings; third-quarter closings total $36.9 million against $206.9 million in the fourth quarter of 2025 (our sums of the 8-Ks). Debt was 1.19 times net assets at September 30 (our arithmetic; 1.27 times at June 30) and asset coverage 184% (178% at June 30) against a 150% minimum, per the 10-Q of November 6, 2026. A twentieth offer, for up to 13,493,156 shares (5.0% of 269,863,125 outstanding at September 30, 2026), opened October 28, 2026 and expires November 30, 2026 (Schedule TO-I, accession 0001104659-26-119625).

Key takeaways

  • Nineteen tender results since April 2022. The fund took every tendered share in the first 17, including February 2026 when holders tendered 105.9% of the 5% limit (15,179,052 shares against 14,333,861). Then 177.7% of the limit in May (56.3% accepted) and 128.7% in August (77.7% accepted).
  • Requests fell 29% from May to August (25.3 million to 17.8 million shares, our arithmetic), but 3.98 million shares were still not taken in August (about $39 million at $9.77) and 11.06 million in May (about $108 million), our arithmetic. A holder who put the leftover back each quarter was about 90% out after two rounds (our arithmetic: 56.3% plus 43.7% x 77.7%).
  • The pool of sellers is narrower than it looks. Shares bought in the last 12 months are ineligible, a “one-year lock-up period” in the offer. By our estimate the 17.8 million requests were about 8% of the roughly 220 million shares that could be tendered, not 6.4% of all shares.
  • New money has dried up. Private-offering closings were $206.9 million in the fourth quarter of 2025, $100.1 million in the first of 2026, $43.1 million in the second and $36.9 million in the third (our sums of the monthly 8-Ks); the October 1 closing was $8.1 million. In the first half of 2026 repurchases of $289.0 million exceeded new shares ($143.2 million) plus reinvested distributions ($55.1 million) by $90.7 million; over nine months repurchases of $424.6 million exceeded new shares ($180.1 million) plus reinvested distributions ($79.7 million) by $164.8 million (our arithmetic).
  • The balance sheet moved the other way until June and then eased. Debt rose $229.8 million in six months to $3,454.0 million while net assets fell to $2,709.7 million (1.14x to 1.27x debt to net assets, asset coverage 188% to 178%); in the third quarter debt fell $347.5 million to $3,106.5 million and net assets to $2,617.0 million, so the ratios were 1.19x and 184% at September 30 (our arithmetic for the ratios). NAV per share, $9.70 at September 30, 2026, is down 6.6% from the September 2024 peak (our arithmetic).
  • Income covered the payout in the first nine months of 2026 (net investment income of $190,284,000 against $180,124,000 of distributions, 105.6%, our arithmetic), after it fell short in 2025 (95.0%). The monthly distribution has gone from $0.09 to $0.068, and 17 borrowers worth $48.8 million (0.9% of investments at fair value) were on non-accrual at September 30, 2026, including First Brands Group.

CSV · 499 rows

Monroe Capital Income Plus Corporation (MCIP): tender offers, NAV, flows, distributions, leverage and non-accruals, 2021-2026

470 rows from 19 Schedule TO-I/A results, the August 2026 Schedule TO and Offer to Purchase, private-offering 8-Ks, monthly NAV 8-Ks, the 10-K for 2025 and 10-Qs for 2024 to September 2026, the proxy statement and the October 20, 2026 8-K: shares tendered and accepted per offer, price and cash paid, NAV, closings, flows, debt and asset coverage, non-accruals, income against distributions and fees.

What MCIP is, in one paragraph

MCIP is the private-credit fund of Monroe Capital, a Chicago lender that says it focuses on lower middle-market companies in the United States and Canada (10-K). It is a BDC that does not trade on an exchange and sells its shares to investors in a private offering under Regulation D or Regulation S, not in a public one. Its $5.51 billion portfolio at September 30, 2026 was 85.0% senior secured loans at fair value ($5.96 billion and 85.6% at June 30), with a weighted average contractual coupon yield of 9.4% (10-Q). In October 2024 an affiliate of Wendel SE agreed to buy a 75% interest in Monroe Capital, a change of control of the adviser that stockholders were asked to approve at a February 2025 special meeting (proxy statement). The exit is a quarterly tender offer that the board, in its own words, controls: “The Board has complete discretion to determine whether we will engage in any share repurchase and, if so, the terms of such repurchase.” For the other funds in this space see the non-traded BDC list, where MCIP ranks fifteenth by net assets, and the private credit redemptions tracker.

Nineteen tender offers: seventeen filled, then two prorated

Every row is the result MCIP filed in the Schedule TO-I/A that closes the offer. The limit is 5% of shares outstanding at the previous quarter-end (per the 10-Q); the filings do not give a separate “shares requested” figure beyond the tendered count, so “request” below means shares validly tendered and not withdrawn.

Offer expiredLimit (shares)Shares tenderedRequest as % of limitShare of request paidPriceCash paid
Dec 26, 20249,049,385932,56710.3%100%$10.39$9.7M
Mar 27, 20259,935,225774,9687.8%100%$10.37$8.0M
May 27, 202511,828,1641,391,45011.8%100%$10.33$14.4M
Sep 18, 202512,421,0033,773,41230.4%100%$10.19$38.5M
Dec 17, 202513,485,7186,664,44449.4%100%$9.98$66.5M
Feb 27, 202614,333,86115,179,052105.9%100%$9.87$149.8M
May 29, 202614,229,10125,287,143177.7%56.3%$9.77$139.0M
Aug 31, 202613,872,18317,848,959128.7%77.7%$9.77$135.5M

The eleven offers before December 2024 (April 2022 to September 2024) drew requests of 4.9% to 37.1% of the limit, the high being 2,050,939 shares in December 2023. The three 2026 offers alone account for $424.4 million of the $668.2 million paid across all nineteen (63.5%, our sums). The first sign of change was December 2025, when requests reached 49.4% of the limit. The February 2026 result then carried this sentence: “The Company is pleased to announce that the Company is fulfilling all repurchase requests this quarter, as it has done every quarter since inception.” The fund did that by buying 5.9% more than the limit, which Rule 13e-4(f)(1) allows. It did not do it in May or in August. The twentieth offer, open until November 30, 2026, has no result yet.

A note on the filing itself: the March 2025 amendment swaps the price and the aggregate figures (it reads “$8,036,415.05 per Share” and “$10.37” as the total). The numbers above use $10.37 a share and $8,036,415.05 in total, which agree with the shares tendered.

What changed since the August offer

The August offer was launched on August 3, 2026 (Schedule TO). It sought up to 13,872,183 shares, which “represents approximately 5.0% of the Company’s Common Stock outstanding as of June 30, 2026,” and the Schedule TO says the fund will use cash on hand and does “not intend to use borrowed funds to purchase the Shares.” The filings from August 7 to November 6, 2026 are:

  • August 7, 10-Q. June 30 balance sheet and first-half results, which the November 6 10-Q (last item) supersedes where the tables say so.
  • August 11, 8-K. The annual meeting finally elected its one nominee (93,486,562 votes for, 3,058,058 withheld) after being adjourned on June 16 and July 28 “because a quorum was not present.” A quorum needed one third of the 286,596,455 shares outstanding, 95,522,598 shares; the 96.5 million votes cast on August 11 cleared it by about one million (our sum).
  • August 20, 8-K. July NAV $9.77; $0.068 distribution; $16.3 million of shares sold on August 3 at $9.77.
  • September 4, TO-I/A. The 77.7% result above.
  • September 21, 8-K. NAV at August 31, 2026 of $9.75; a $0.068 distribution to holders of record September 22, payable about September 28; and 964,518 shares sold on September 1 at $9.75 for $9,404,050.
  • October 20, 8-K. NAV at September 30, 2026 of $9.70, the lowest NAV in the monthly series we read; a $0.068 distribution to holders of record October 21, payable about October 28; and 839,725 shares sold on October 1 at $9.70 for $8,145,328, the smallest monthly closing in the filings we read (13.4% below September, our arithmetic).
  • October 28, Schedule TO-I. The twentieth offer: up to 13,493,156 shares, “approximately 5.0%” of the 269,863,125 shares outstanding at September 30, 2026. That share count is 7,580,539 (2.7%) below the 277,443,664 at June 30, and the limit is 2.7% below August’s 13,872,183 (our arithmetic). The offer expires at 11:59 p.m. Eastern on November 30, 2026 unless extended. The price is that of the most recent private-offering closing before expiry, expected on or about November 2, 2026; at the $9.70 of October 1 the maximum cost would be $130,883,613.20, the filing’s own figure. Section 7 says the fund “will use cash on hand”, while Section 2 says the board may use cash on hand, borrowings and sales of investments; if tenders exceed the limit the fund may accept more shares under Rule 13e-4(f)(1)(ii) or prorate. Shares bought on or after October 28, 2025 are ineligible because of the one-year lock-up. A holder may withdraw at any time before expiry, and after December 29, 2026 if the shares have not been accepted.
  • November 6, 10-Q. September 30 balance sheet and nine-month results (accession 0001742313-26-000066): net assets $2,616,998,000, 269,863,125 shares, NAV $9.70, debt principal $3,106,509,000, asset coverage 184%, 17 borrowers on non-accrual at $48.8 million, and subsequent events (a $0.068 distribution paid October 28, $16.5 million of share issuances after September 30 and the twentieth tender offer).

The tender price is worth a line. Under the Offer to Purchase it is the price of the most recent closing before expiry, which for the August offer was the August 3 closing at $9.77, the July 31 NAV. Holders who tendered were paid $9.77; the August 31 NAV, published three weeks after the offer closed, was $9.75 (a difference of 0.2%, our arithmetic), and the September 30 NAV was $9.70 (0.7% below the tender price, our arithmetic).

Money in, money out

The private offering used to bring in far more than the tender took out. The statements of changes in net assets show it:

PeriodNew shares soldReinvested distributionsRepurchasesNet (our arithmetic)
2023$541.0M$40.9M$43.3M+$538.5M
2024$717.8M$79.6M$60.1M+$737.4M
2025$920.4M$109.6M$127.8M+$902.3M
First half 2025$486.8M$50.7M$22.4M+$515.1M
First half 2026$143.2M$55.1M$289.0M-$90.7M
Second quarter 2026$43.1M$26.2M$139.0M-$69.7M
Third quarter 2026$36.9M$24.6M$135.5M-$74.0M
First nine months 2026$180.1M$79.7M$424.6M-$164.8M

New sales are the monthly closings reported in Item 3.02 of the 8-Ks. Monthly closings began in October 2025 (the 10-Q notes the change); before that the 8-Ks show less frequent closings.

QuarterClosings (month by month)Quarter total (our sum)
Q4 2025Oct $73.0M, Nov $73.4M, Dec $60.5M$206.9M
Q1 2026Jan $46.3M, Feb $25.6M, Mar $28.2M$100.1M
Q2 2026Apr $19.7M, May $11.5M, Jun $11.9M$43.1M
Q3 2026Jul $11.2M, Aug $16.3M, Sep $9.4M$36.9M
Q4 2026 (so far)Oct $8.1M, Nov 2 $8.3M$16.5M (two closings, per the 10-Q)

The third quarter of 2026 is 82% below the fourth quarter of 2025 (our arithmetic). The October 1 closing, filed in the October 20 8-K ($8,145,328), is the smallest of the thirteen monthly closings; September's $9,404,050 was the smallest before it. In the first half of 2026 the fund bought back 29,428,321 shares, 10.3% of the 286.7 million it had at December 31, 2025 (our arithmetic), and its share count fell from 286,677 thousand to 277,444 thousand.

The one-year lock-up changes the denominator

The Offer to Purchase says: “If you purchased your Shares on or after August 3, 2025, your Shares are ineligible to be repurchased pursuant to the Offer because they are subject to a one-year lock-up period pursuant to the subscription agreement” (it continues that the holder entered it when buying). The ten private-offering closings from September 2, 2025 to June 1, 2026 sold 57,511,771 shares (our sum of the 8-Ks), 20.7% of the 277,443,664 shares outstanding at June 30, 2026. Taking them out leaves about 219.9 million eligible shares, and the 17,848,959 tendered in August were 8.1% of that (our estimate; the filings we read do not say whether shares issued through dividend reinvestment carry the same lock-up, so if they do, the true share is higher). The quarterly “5% of shares outstanding” limit is therefore closer to 6.3% of the shares that can actually be sold (13,872,183 / 219.9 million, our arithmetic). The offer opened on October 28, 2026 moves the cutoff to shares bought on or after October 28, 2025; we have not recomputed the eligible share count for it.

DateNAV per shareNet assetsShares outstanding
Dec 31, 2021$10.10$369.4M36,565K
Dec 31, 2022$10.13$754.9M74,533K
Dec 31, 2023$10.24$1,302.7M127,233K
Sep 30, 2024 (peak)$10.39$1,880.0M180,988K
Dec 31, 2024$10.37$2,059.7M198,704K
Jun 30, 2025$10.25$2,546.3M248,420K
Sep 30, 2025$10.03$2,705.1M269,714K
Dec 31, 2025$9.87$2,830.6M286,677K
Mar 31, 2026$9.78$2,783.4M284,582K
Jun 30, 2026$9.77$2,709.7M277,444K
Aug 31, 2026$9.75not reportednot reported
Sep 30, 2026$9.70$2,617.0M269,863K

NAV rose from $10.10 at the end of 2021 to $10.39 at September 30, 2024, and has been lower at every quarter-end since: $10.37, $10.33, $10.25, $10.03, $9.87, $9.78, $9.77, then $9.75 at August 31 and $9.70 at September 30. That is 6.6% below the peak and 1.7% below December 2025 (our arithmetic). The 2025 decline came with a $113.8 million net change in unrealized losses; in the first half of 2026 unrealized changes were a gain of $4.4 million but net realized losses on investments were $40.6 million ($28.9 million of it in the second quarter), against $1.6 million a year earlier. For the nine months, net realized losses on investments were $58.3 million ($17.7 million in the third quarter) and the net change in unrealized gain was $0.7 million (10-Q of November 6, 2026). For 2025 as a whole, a holder who bought at $10.37 and took the $1.029 of distributions without reinvesting would be up 5.1% (our arithmetic: $9.87 minus $10.37 plus $1.029, over $10.37).

Distributions against income

PeriodNet investment incomeDistributions declaredCoverage (our arithmetic)Declared per shareNet increase in net assets
2023$115.9M$105.3M110.0%$1.110$114.6M
2024$195.9M$186.8M104.8%$1.160$206.5M
2025$236.8M$249.2M95.0%$1.029$117.7M
First half 2026$131.0M$123.8M105.8%$0.431$93.5M
Second quarter 2026$63.7M$59.7M106.8%n/a$55.7M
Third quarter 2026$59.3M$56.4M105.2%$0.204$37.8M
First nine months 2026$190.3M$180.1M105.6%$0.635$131.3M

The per-month rate was $0.09 in most months of 2024 and 2025 (with four $0.02 supplemental dividends in 2024 and $0.08 for the June and September 2025 record dates), $0.082 for the September 30 and November 21, 2025 record dates, $0.075 for December to February, $0.071 for March to May and $0.068 from June 2026, repeated in July, August, September and October (record date October 21, payable about October 28). At $0.068 and the $9.70 NAV that is 8.4% a year (our arithmetic: $0.068 x 12 / $9.70). In 2025, when distributions of $249.2 million exceeded net investment income by $12.4 million (our arithmetic), the net increase in net assets was only $117.7 million. In the first half of 2026 income covered the payout, but net assets still fell $120.9 million, mostly because repurchases of $289.0 million outran new shares and reinvested distributions (our arithmetic). Over nine months income again covered the payout and net assets fell $213.6 million, from $2,830.6 million to $2,617.0 million, with repurchases of $424.6 million (our arithmetic from the 10-Q of November 6, 2026).

Payment-in-kind interest is a small part of income: $9.96 million in the first half of 2026, 3.3% of total investment income of $298.5 million, against 3.9% in 2025 and 3.4% in 2023 (our arithmetic).

Leverage: debt rose through June, then fell

DateDebt (principal)Net assetsDebt / net assets (our arithmetic)Asset coverage
Dec 31, 2024$2,151.7M$2,059.7M1.04x196%
Jun 30, 2025$2,743.6M$2,546.3M1.08x193%
Sep 30, 2025$2,775.5M$2,705.1M1.03x197%
Dec 31, 2025$3,224.2M$2,830.6M1.14x188%
Mar 31, 2026$3,296.4M$2,783.4M1.18x184%
Jun 30, 2026$3,454.0M$2,709.7M1.27x178%
Sep 30, 2026$3,106.5M$2,617.0M1.19x184%

The 1940 Act lets a BDC borrow as long as asset coverage stays at 150% or more. MCIP was at 178% at June 30 and at 184% at September 30, 2026. The cash-flow statement shows how the first half went: borrowings of $1,268.8 million and repayments of $1,037.4 million, a net $231.4 million of new debt, against $289.0 million of repurchases and $68.6 million of cash distributions, while the fund still made a net $156.4 million of new investments. In the third quarter debt then fell $347.5 million: the fund invested $183.0 million ($15.0 million in 16 new and $168.0 million in 92 existing portfolio companies) and received $614.7 million of sales and principal repayments, a net decrease in investments of $431.7 million (10-Q of November 6, 2026). The Schedule TO says the August offer would be paid with cash on hand; the filings do not tie any one use of borrowing to any one use of cash, and we do not claim they do.

For a sense of scale, here is a stylised calculation (our arithmetic; not a forecast and not a company statement). If each quarter's repurchase were about $135.5 million, the August amount, and all of it were funded with new debt, with no new shares sold, no income and no asset sales, asset coverage would fall to 150% after about 4.8 quarters (net assets of $2,709.7 million less $135.5 million a quarter, against debt of $3,454.0 million plus $135.5 million). The fund has other levers: it can sell loans, which it did ($745.7 million of sales and repayments in the half), and the board can cut the tender size. The point is how much of the 150% headroom a debt-funded 5% programme would use. Redone with September 30 figures (net assets $2,617.0 million, debt $3,106.5 million) and the same assumptions, asset coverage would reach 150% after about 5.2 quarters (our arithmetic).

Credit: non-accruals and First Brands

DateBorrowers on non-accrualFair value% of investments at fair value
Dec 31, 20234$12.4M0.5% (our arithmetic)
Dec 31, 202411$28.7M0.7% (our arithmetic)
Jun 30, 202513$41.3M0.8% (our arithmetic)
Sep 30, 202514$73.8M1.4% (our arithmetic)
Dec 31, 202517$67.7M1.2%
Mar 31, 202620$79.0M1.4% (our arithmetic)
Jun 30, 202619$71.4M1.2%
Sep 30, 202617$48.8M0.9%

Non-accruals are small as a share of the book, 0.9% at fair value at September 30, 2026 (1.2% at June 30), but the count has risen from four borrowers at the end of 2023 to seventeen (twenty at March 31, 2026), and fair value is after write-downs, so it understates the loans' original size. First Brands Group, LLC is marked non-accrual at both December 31, 2025 and June 30, 2026. Its four positions carried an amortized cost of $64.2 million at June 30, 2026 (2.4% of net assets) and a fair value of $2.4 million (our sums of the four lines), against a cost of $64.5 million and fair value of $5.1 million at December 31, 2025. At December 31, 2024 the fund held one position in the name, $14.0 million of cost at $13.1 million of fair value. At September 30, 2026 the four positions were still on non-accrual, with an amortized cost of $64.2 million (2.5% of net assets) and a fair value of $2.6 million (our sums of the four lines). The schedule of investments says only that the positions are on non-accrual; we have not read any further explanation in these filings.

Fees: the cost of leverage sits in the fee base

The base management fee is charged on average total assets, including assets bought with borrowed money. The contract rate is 1.50%; a 2022 waiver brought it to 1.25%, and on January 22, 2026 the adviser agreed to waive it further to 1.0% for January 1 to December 31, 2026, with no recoupment. With total assets of $6,225.9 million and net assets of $2,709.7 million at June 30, a 1.0% fee on total assets is about 2.3% of net assets, and 1.25% would be 2.9% (our arithmetic). The incentive fee is 12.5% of pre-incentive net investment income above a 6% annual hurdle, with a 100% catch-up up to 1.7143% a quarter (15% and 1.76% before the 2022 waiver). It is charged on income, not on NAV: the 10-Q says “it is possible that the Company may pay an incentive fee in a quarter where it incurs a loss,” and the second quarter's $9.1 million incentive fee came in a quarter with $30.2 million of net realized losses, partly offset by $22.1 million of unrealized gains.

In the first half of 2026, base fees of $38.2 million less $7.6 million of waivers, plus $18.7 million of incentive fees, came to $49.3 million, which is 3.6% a year of average net assets (our arithmetic). Interest and debt financing costs were another $108.9 million. If the fund lists on an exchange, the base fee becomes 1.75% of average invested assets, the 10-Q states; we did not find a listing plan in the 8-Ks and 10-Q we read.

What the numbers mean for three decisions

Asking to sell. The last two prorations took 56.3% and 77.7% of each request. Requests fell 29% between May and August, which points in the right direction, but they were still 129% of the limit. The new-money line is the problem: with $36.9 million coming in a quarter against about $135 million a quarter going out, the only things that shorten the queue are fewer requests, a share count that keeps falling, or more borrowing. The offer that opened on October 28, 2026 has a limit of 13,493,156 shares, 2.7% below August’s because the share count fell 2.7% between June 30 and September 30 (our arithmetic; our October 21 estimate was about 13.4 million). If requests equal August’s 17.8 million, the fill would be about 75.6% (our arithmetic: 13,493,156 / 17,848,959); the real requests will be known from the final amendment after November 30, 2026. Shares bought in the last 12 months cannot be tendered at all.

Holding. Income covers the $0.068 payout. NAV has drifted down 1.7% in 2026 ($9.87 to $9.70, our arithmetic) and non-accruals are 0.9% of fair value at September 30. The pressure points are the pace of requests and the 1.19x leverage ratio (1.27x at June 30), not the quality of the average loan. Distributions can be reinvested through the DRIP, which issued 5,618,951 shares worth $55.1 million in the first half and 8,135,595 shares worth $79.7 million in the nine months.

Adding. New shares are sold at NAV (the $9.70 of October 1) and carry a one-year lock-up before they can even join the queue. Since April 2026 monthly closings have run from $8.1 million to $19.7 million, so the offering is open but small; a year earlier a single closing (September 2, 2025) took in $226.8 million.

This is analysis of public documents, not investment, legal or tax advice. Whether a repurchase is taxable and how it interacts with the rest of a portfolio is a question for a tax adviser; the Offer to Purchase says most holders recognise gain or loss on a sale.

Related reading: the HPS Corporate Lending Fund and BlackRock Private Credit Fund pages cover two other BDCs through the same filings, and evergreen funds compared puts private equity, infrastructure and credit funds side by side.

FAQ

Filing alert · free

An email when Monroe Capital Income Plus (MCIP) files with the SEC

An email the day Monroe Capital Income Plus (MCIP) files something new, with the link to the document on the SEC site.

All figures are from MCIP's SEC filings read on EDGAR on October 6, October 21, October 30 and November 7, 2026, including the Schedule TO-I and Offer to Purchase of October 28, 2026 (accession 0001104659-26-119625) and the Form 8-K of October 20, 2026 (accession 0001742313-26-000062): nineteen Schedule TO-I/A result filings (April 2022 to September 2026), the August 3, 2026 Schedule TO and Offer to Purchase, seventeen Form 8-Ks on private-offering closings and monthly NAV (August 2024 to September 21, 2026), the annual report for 2025 (accession 0001742313-26-000013) and quarterly reports to September 30, 2026 (accession 0001742313-26-000046 for June 30 and 0001742313-26-000066, filed November 6, 2026, for September 30), the 2026 and 2024 proxy statements and the 8-Ks of June 16, July 28 and August 11, 2026. Request percentages, sums across periods, coverage and leverage ratios, the lock-up estimate and the stylised leverage calculation are our arithmetic or estimate. This is analysis of public documents, not investment, legal or tax advice.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.